Background: Biomarkers were correlated with mortality in critically ill COVID-19 patients. No
prediction tools exist for noncritically ill COVID-19 patients. We aimed to compare the …

Background Multiple Biomarkers have recently been shown to be elevated in COVID-19, a
respiratory infection with multi-organ dysfunction; however, information regarding the …

Multiple Biomarkers have recently been shown to be elevated in COVID-19, a respiratory
infection with multi-organ dysfunction; however, information regarding the prognostic value …

Aims: While COVID-19 affects the cardiovascular system, the potential clinical impact of
cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown …

COVID-19 has been associated with cardiovascular consequences, including myocardial
infarction, thromboembolic events, arrhythmia, and heart failure. Numerous overlapping …

Inflammatory biomarkers may be associated with disease severity and increased mortality in
COVID-19 patients but have not been studied in North American populations. We sought to …

Summary Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is erupting and
spreading globally. Cardiovascular complications secondary to the infection have caught …

In early December 2019, the coronavirus disease (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China. As of …

Aims SARS-CoV-2 infection is associated with adverse outcomes in patients with
cardiovascular disease. Here, we analyzed whether specific biomarkers predict the clinical …

Background: Accumulating evidence has revealed that coronavirus disease 2019 (COVID-
19) patients may be complicated with myocardial injury during hospitalization. However …